EUDA Health (NASDAQ:EUDA) Announces Quarterly Earnings Results

EUDA Health (NASDAQ:EUDA) issued its quarterly earnings data on Tuesday. The company reported ($0.17) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.57), reports. The business had revenue of $1.73 million during the quarter, compared to the consensus estimate of $9.61 million.

EUDA Health Price Performance

NASDAQ:EUDA opened at $14.30 on Thursday. EUDA Health has a 1 year low of $5.26 and a 1 year high of $86.00. The stock has a 50-day moving average price of $15.56 and a two-hundred day moving average price of $13.69.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of EUDA Health in a research note on Wednesday, August 5th. One equities research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $55.00.

EUDA Health Company Profile

EUDA Health Holdings Limited is a digital health company focused on using technology to improve access to healthcare services. The company operates through subsidiaries and develops digital platforms intended to connect patients with healthcare providers and support the delivery of healthcare services.

Its activities include telemedicine and other technology-enabled healthcare solutions, such as facilitating virtual consultations, healthcare appointments and related services. EUDA has also pursued artificial-intelligence applications in sexual health, including technology designed to support the assessment of certain male sexual-health conditions.

The company is based in Singapore and has focused its operations on the Southeast Asian healthcare market.